Angiotensin-converting enzyme inhibition alters clusterin mRNA expression in the kidney following renal mass reduction

被引：6
|
作者：
Olson, BA [1 ]
Ali, SM [1 ]
Contino, LC [1 ]
Brooks, DP [1 ]
Laping, NJ [1 ]
机构：
[1] SmithKline Beecham Pharmaceut, Dept Renal Pharmacol, SB Pharmaceut, King Of Prussia, PA 19406 USA
来源：
PHARMACOLOGY | 1998年 / 57卷 / 01期
关键词：
sulfated glycoprotein 2; apolipoprotein J; captopril;
D O I：
10.1159/000028221
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The effect of the angiotensin-converting enzyme inhibitor captopril on clusterin mRNA was examined in partially nephrectomized male rats. Urine protein excretion was measured 3, 7, and 28 days after removal of five sixths of the renal mass. Nephrectomy caused a progressive increase in clusterin mRNA levels in the remnant kidney. Maximal clusterin mRNA levels occurred 7 days after nephrectomy and declined 28 days after nephrectomy. Captopril, 250 mg/ml in drinking water, prevented the injury-induced increase in clusterin mRNA at 7 and 28 days. Captopril had no effect on clusterin in sham-operated rats. As expected, the urine protein excretion increased progressively after nephrectomy, and this was attenuated by administration of captopril in the drinking water. Therefore, clusterin is a marker of renal injury which, along with proteinuria, is modulated by angiotensin-converting enzyme inhibition.
引用
收藏
页码：13 / 19
页数：7
相关论文
共 50 条
  • [41] Renal angiotensin-converting enzyme and angiotensin-converting enzyme 2 gender differences in fetal programmed hypertension
    Stone, Ryan
    Su, Yixin
    Rose, James C.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2011, 204 : S207 - S208
  • [42] Alterations in Circulatory and Renal Angiotensin-Converting Enzyme and Angiotensin-Converting Enzyme 2 in Fetal Programmed Hypertension
    Shaltout, Hossam A.
    Figueroa, Jorge P.
    Rose, James C.
    Diz, Debra I.
    Chappell, Mark C.
    HYPERTENSION, 2009, 53 (02) : 404 - 408
  • [43] Angiotensin-converting enzyme II in the heart and the kidney
    Danilczyk, U
    Penninger, JM
    CIRCULATION RESEARCH, 2006, 98 (04) : 463 - 471
  • [44] ANGIOTENSIN-CONVERTING ENZYME IN DEVELOPING LUNG AND KIDNEY
    WALLACE, KB
    BAILIE, MD
    HOOK, JB
    AMERICAN JOURNAL OF PHYSIOLOGY, 1978, 234 (03): : R141 - R145
  • [45] Angiotensin-converting enzyme inhibition and fibrinolytic balance
    Tetsuya Matsumoto
    Minoru Horie
    Hypertension Research, 2011, 34 : 448 - 449
  • [46] INHIBITION OF ANGIOTENSIN-CONVERTING ENZYME - THERAPEUTIC IMPLICATIONS
    ROTMENSCH, HH
    VLASSES, PH
    FERGUSON, RK
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1982, 18 (10): : 981 - 985
  • [47] Angiotensin-converting enzyme inhibition by Brazilian plants
    Braga, Fernao C.
    Serra, Carla P.
    Viana, Nilton S., Jr.
    Oliveira, Alaide B.
    Cortes, Steyner F.
    Lombardi, Julio A.
    FITOTERAPIA, 2007, 78 (05) : 353 - 358
  • [48] Angiotensin-converting enzyme inhibition and fibrinolytic balance
    Matsumoto, Tetsuya
    Horie, Minoru
    HYPERTENSION RESEARCH, 2011, 34 (04) : 448 - 449
  • [49] The angiotensin-converting enzyme inhibition post revascularization
    Kjoller-Hansen, L
    Steffensen, R
    Grande, P
    EUROPEAN HEART JOURNAL, 2000, 21 : 168 - 168
  • [50] Renal GLUT1 reduction depends on angiotensin-converting enzyme inhibition in diabetic hypertensive rats
    da Silva, Ariel S.
    Dias, Lucinara D.
    Borges, Julia F.
    Markoski, Melissa M.
    de Souza, Martina S.
    Irigoyen, Maria C.
    Machado, Ubiratan F.
    Schaan, Beatriz D.
    LIFE SCIENCES, 2013, 92 (24-26) : 1174 - 1179
12345